AC
Armistice Capital’s Agios Pharmaceuticals AGIO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $38.8M | Sell |
1,168,000
-880,000
| -43% | -$29.3M | 0.67% | 18 |
|
2025
Q1 | $60M | Sell |
2,048,000
-216,304
| -10% | -$6.34M | 0.9% | 10 |
|
2024
Q4 | $74.4M | Buy |
2,264,304
+57,234
| +3% | +$1.88M | 1.02% | 16 |
|
2024
Q3 | $98.1M | Buy |
2,207,070
+127,919
| +6% | +$5.68M | 1.57% | 7 |
|
2024
Q2 | $89.7M | Sell |
2,079,151
-884,849
| -30% | -$38.2M | 1.13% | 7 |
|
2024
Q1 | $86.7M | Sell |
2,964,000
-560,000
| -16% | -$16.4M | 1.15% | 8 |
|
2023
Q4 | $78.5M | Buy |
3,524,000
+200,000
| +6% | +$4.45M | 1.07% | 10 |
|
2023
Q3 | $82.3M | Buy |
3,324,000
+68,000
| +2% | +$1.68M | 1.26% | 5 |
|
2023
Q2 | $92.2M | Sell |
3,256,000
-204,000
| -6% | -$5.78M | 1.33% | 7 |
|
2023
Q1 | $79.5M | Buy |
3,460,000
+710,000
| +26% | +$16.3M | 1.14% | 16 |
|
2022
Q4 | $77.2M | Buy |
2,750,000
+826,000
| +43% | +$23.2M | 1.35% | 15 |
|
2022
Q3 | $54.4M | Buy |
+1,924,000
| New | +$54.4M | 0.94% | 25 |
|